Innovations in Oncology Care: Florida Cancer Specialists Lead the Way in Patient-Centered Treatment

Advancements in Oncology Care at Florida Cancer Specialists

Florida Cancer Specialists & Research Institute (FCS), recognized as the largest community oncology practice in Florida, is making significant strides in medically integrated oncology care. This was highlighted at the recent NCODA 2026 International Spring Forum in Denver, where FCS leaders showcased their innovative approaches to specialty pharmacy operations, patient navigation, and more, all contributing to improved patient outcomes.

FCS’s President and Managing Physician, Dr. Lucio N. Gordan, expressed enthusiasm for the opportunity to share knowledge with peers and industry experts. The presentations included various workshops focusing on critical areas such as clinical innovation and operational excellence in oncology. Notable contributions came from experts like Destiny Carroll, PharmD, and Nicole Bentivegna, PharmD, showcasing cutting-edge therapeutic models and treatment patterns.

One of the key presentations addressed optimizing JAK inhibitor therapy for patients with Myelofibrosis, which reflects FCS’s commitment to utilizing the latest advancements in cancer treatment. Another prominent topic discussed was the treatment patterns observed in patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, emphasizing real-world evidence in treatment decision-making and enhancing care delivery.

FCS prides itself on its Rx To Go service, an in-house specialty pharmacy that exclusively serves its patients across Florida. This service exemplifies FCS's dedication to personalized care, ensuring timely access to necessary medications. According to Paul Chadwick, FCS’s Chief Value and Procurement Officer, this initiative is part of an overarching strategy to redefine excellence in oncology care by closely integrating pharmacy services with medical treatments.

Furthermore, FCS is dedicated to addressing gaps in cancer treatment access, notably for veteran patients. Their initiative, “Leave No Veteran Patient Behind,” aims to expand access to clinical trials, ensuring that veterans receive the best possible care tailored to their unique needs.

With over 40 years of experience, Florida Cancer Specialists has embraced innovation, significantly influencing the oncology landscape. Their efforts have led to a dramatic transformation in cancer care delivery, particularly through robust clinical research programs that provide patients access to pioneering clinical trials. It is noteworthy that many drugs currently available to patients first entered the market via trials conducted at FCS.

In recent years, they have remained at the forefront of research among private oncology practices in Florida, connecting patients with new therapies before these treatments receive FDA approval. FCS’s commitment to personalized, precision oncology is evident in their tailored treatment plans that leverage the latest advancements to enhance patient outcomes.

In summary, Florida Cancer Specialists & Research Institute is spearheading the evolution of cancer care through innovative practices and a patient-focused approach. Their efforts not only highlight their leadership in oncology but also serve as a beacon of hope for patients navigating the challenges of cancer treatment. As they continue to set new standards in the field, FCS remains committed to improving the lives of those affected by cancer throughout Florida and beyond.